1. Home
  2. UTHR vs NWSA Comparison

UTHR vs NWSA Comparison

Compare UTHR & NWSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • NWSA
  • Stock Information
  • Founded
  • UTHR 1996
  • NWSA 2012
  • Country
  • UTHR United States
  • NWSA United States
  • Employees
  • UTHR N/A
  • NWSA N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • NWSA Newspapers/Magazines
  • Sector
  • UTHR Health Care
  • NWSA Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • NWSA Nasdaq
  • Market Cap
  • UTHR 16.2B
  • NWSA 16.8B
  • IPO Year
  • UTHR 1999
  • NWSA N/A
  • Fundamental
  • Price
  • UTHR $359.23
  • NWSA $27.86
  • Analyst Decision
  • UTHR Buy
  • NWSA Strong Buy
  • Analyst Count
  • UTHR 14
  • NWSA 4
  • Target Price
  • UTHR $370.86
  • NWSA $40.33
  • AVG Volume (30 Days)
  • UTHR 313.6K
  • NWSA 2.4M
  • Earning Date
  • UTHR 02-19-2025
  • NWSA 02-05-2025
  • Dividend Yield
  • UTHR N/A
  • NWSA 0.72%
  • EPS Growth
  • UTHR 25.10
  • NWSA 158.28
  • EPS
  • UTHR 22.72
  • NWSA 0.62
  • Revenue
  • UTHR $2,756,200,000.00
  • NWSA $10,163,000,000.00
  • Revenue This Year
  • UTHR $26.32
  • NWSA $5.36
  • Revenue Next Year
  • UTHR $10.37
  • NWSA $3.54
  • P/E Ratio
  • UTHR $15.82
  • NWSA $44.94
  • Revenue Growth
  • UTHR 25.04
  • NWSA 2.66
  • 52 Week Low
  • UTHR $208.62
  • NWSA $22.65
  • 52 Week High
  • UTHR $417.82
  • NWSA $30.04
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 43.90
  • NWSA 37.83
  • Support Level
  • UTHR $358.82
  • NWSA $28.93
  • Resistance Level
  • UTHR $383.00
  • NWSA $29.56
  • Average True Range (ATR)
  • UTHR 9.97
  • NWSA 0.47
  • MACD
  • UTHR -0.80
  • NWSA -0.26
  • Stochastic Oscillator
  • UTHR 29.51
  • NWSA 16.06

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

About NWSA News Corporation

News Corporation is a diversified media conglomerate with significant presence in the us, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. The company also has a strong presence in the Australian subscription video market through 65%-owned Foxtel, and streaming platforms such as sport-focused Kayo and entertainment-focused Binge. Its 61%-owned REA Group is the dominant property listings business in Australia. In addition, it owns Harper Collins, one of the biggest book publishers in the world, and has a sizable us digital property advertising business, Move.

Share on Social Networks: